US Patent Issued to Ablynx on Feb. 17 for "Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies" (Belgian Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,901, issued on Feb. 17, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium).

"Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies" was invented by Veerle Snoeck (Zingem, Belgium), Marie-Ange Buyse (Merelbeke, Belgium) and Judith Baumeister (Mechelen, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods, assays and techniques for detecting and/or measuring anti-drug antibodies that bind to a protein, polypeptide or other compound or molecule that comprises at least one immunoglobulin variable domain with an exposed C-terminal region."

The patent was fil...